![Anthony Zook](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anthony Zook
Directeur Général chez
NEOGENOMICS, INC.
Fortune : 2 M $ au 31/05/2026
Profil
Mr. Anthony P.
Zook is an Independent Director at Adaptin Bio, Inc., a Chief Executive Officer & Director at NeoGenomics, Inc., a Chairman at Algorithm Sciences, Inc. and an Executive Chairman at Voltron Therapeutics, Inc. He is on the Board of Directors at Adaptin Bio, Inc., NeoGenomics, Inc., ViralClear Pharmaceuticals, Inc. and Healthcare Leadership Council.
Mr. Zook was previously employed as an Independent Director by BioSig Technologies, Inc., a Chief Executive Officer by Innocoll AG, a Chief Executive Officer & Member-Supervisory Board by Innocoll Holdings Plc, a Chief Executive Officer by Innocoll Biotherapeutics, a Chief Executive Officer & Director by VIVUS, Inc., an Executive Vice President-Global Commercial by AstraZeneca PLC, a President & Chief Executive Officer by Astra USA, Inc., a President & Chief Executive Officer by AstraZeneca Pharmaceuticals LP, a Director-Pennsylvania Division by American Cancer Society, Inc., a Partner by Lucius Partners LLC, and a President by MedImmune Ventures, Inc. He also served on the board at Inhibikase Therapeutics, Inc., AltheRx, Inc., Melinta Subsidiary Corp., First State Innovation, Inc., Frostburg State University, MedImmune LLC, National Pharmaceutical Council and Pharmaceutical Research & Manufacturers of America.
He received his undergraduate degree from Frostburg State University and an undergraduate degree from The Pennsylvania State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NEOGENOMICS, INC. 0,12 % | 01/04/2026 | 152 011 ( 0,12 % ) | 2 M $ | 31/05/2026 |
Postes actifs de Anthony Zook
| Sociétés | Poste | Début |
|---|---|---|
| NEOGENOMICS, INC. | Directeur Général | 01/04/2025 |
Algorithm Sciences, Inc.
 Algorithm Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company specializing in pulmonary arterial hypertension | Président | - |
Voltron Therapeutics, Inc.
 Voltron Therapeutics, Inc. BiotechnologyHealth Technology Engages in development and discovery of vaccine and immunotherapy center | Président | 28/01/2021 |
Viralclear Pharmaceuticals, Inc.
 Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to fight SARS-CoV-2 virus that causes COVID-19 | Directeur/Membre du Conseil | 28/05/2020 |
Healthcare Leadership Council
 Healthcare Leadership Council Medical/Nursing ServicesHealth Services Provides healthcare services | Directeur/Membre du Conseil | 04/01/2011 |
Anciens postes connus de Anthony Zook
| Sociétés | Poste | Fin |
|---|---|---|
| STREAMEX CORP. | Directeur/Membre du Conseil | 22/04/2022 |
| INNOCOLL HOLDINGS PLC | Directeur Général | 01/03/2019 |
| VIVUS, INC. | Directeur Général | 03/09/2013 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 31/01/2013 |
Formation de Anthony Zook
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
66
Relations au 1er degré
23
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 23 |
|---|---|
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes next-generation therapies | Health Technology |
NeoGenomics, Inc.
 NeoGenomics, Inc. Medical/Nursing ServicesHealth Services Provides genetic and molecular testing services | Health Services |
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures invests in private biotechnology companies located across the globe primarily in North America. The firm focuses on healthcare sectors such as molecules, vaccines, pharmaceutical technologies, medical devices, diagnostics, imaging and healthcare IT. The firm provides financing for seed, early, later and mezzanine stage capital requirements with an investment size ranging from USD 5 - USD 10 million per round. It acts as a lead investor and takes an active role on the board of directors. | Finance |
BioSig Technologies, Inc.
 BioSig Technologies, Inc. Investment Banks/BrokersFinance Operates as an asset tokenization company that provides blockchain technology to tokenize gold and commodities | Finance |
Frostburg State University
 Frostburg State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates voluntary health organization for cancer research | Commercial Services |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Healthcare Leadership Council
Healthcare Leadership Council Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services Operates as a not for profit organization which specializes in research development, information dissemination, education and communication of information to patients | Commercial Services |
First State Innovation, Inc.
 First State Innovation, Inc. Financial ConglomeratesFinance Provides investment services to technology-based and early stage businesses | Finance |
Astra USA, Inc. | |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Altherx, Inc.
 Altherx, Inc. Miscellaneous Commercial ServicesCommercial Services Offers clinical development for overactive bladder and irritable bowel syndrome | Commercial Services |
Innocoll AG
 Innocoll AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Innocoll Holdings Plc
 Innocoll Holdings Plc Pharmaceuticals: MajorHealth Technology Develops specialty pharmaceuticals | Health Technology |
Algorithm Sciences, Inc.
Algorithm Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company specializing in pulmonary arterial hypertension | Health Technology |
Voltron Therapeutics, Inc.
Voltron Therapeutics, Inc. BiotechnologyHealth Technology Engages in development and discovery of vaccine and immunotherapy center | Health Technology |
Viralclear Pharmaceuticals, Inc.
Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to fight SARS-CoV-2 virus that causes COVID-19 | Health Technology |
